Gastric normal | Gastric adenocarcinoma | |
---|---|---|
Number of cases | 13 | 8 (1HGD) |
Male | 4 (31) | 7 (88) (p = 0.02) |
Age | 72 ± 3 | 70 ± 4 (p = 0.45) |
Smoking | ||
Never | 1 (8) | 1 (11) (p = 0.45) |
Ex-smoker | 1 (8) | 2 (22) (p = 0.98) |
Current | 5 (38) | 6 (67) (p = 0.09) |
Missing | 6 (46) | 0 |
Pathological differentiation | ||
Poor | 6 (75) | |
Moderate | 0 | |
Well | 0 | |
Missing | 2 (25) | |
Depth of invasion | ||
T1 | 1 (13) | |
T2 | 2 (25) | |
T3 | 3 (50) | |
T4 | 0 | |
Missing | 1 (13) | |
Metastatic disease | ||
Local (N) | 3 (37.5) | |
Distant (M) | 0 (0) | |
AJCC 2010 Stage | ||
1 | 2 (25) | |
2 | 3 (36) | |
3 | 2 (25) | |
4 | 0 | |
Missing | 1 (13) | |
Treatment | ||
Surgery | 6 (75) | |
Surgery and chemotherapy | 1 (13) | |
Chemotherapy | 0 | |
Chemo-radiotherapy | 0 | |
EMR | 0 | |
Palliative care | 1 (13) | |
Missing | 0 | |
PLK1 mRNA expression | ||
mRNA level ×10 | 2.1 | 18.8 |
Positive expression | 2 (15) | 5 (63) (p = 0.056) |
FOXM1 mRNA expression | ||
mRNA level ×10 | 1.2 | 9.2 |
Positive expression | 0 (0) | 6 (75) (p = 0.001) |